49 research outputs found
Dose response curves for cenicriviroc-dependent inhibition (A) and maraviroc-dependent inhibition (B).
<p>R5, dual and X4-tropic HIV-2 strains are depicted in continuous, dashed and dotted black lines, respectively. HIV-1 R5-tropic strain is depicted using the continuous gray line.</p
Baseline characteristics of the 116 patients.
<p>ART: antiretroviral therapy, ATV: atazanavir, DRV: darunavir, EFV: efavirenz, ETR: etravirine, FTC: emtricitabine, IQR: interquartile range, LPV: lopinavir, MVC: maraviroc, NNRTI: non nucleoside reverse transcriptase inhibitors, NRTI: nucleoside reverse transcriptase inhibitors, NVP: nevirapine, PI: protease inhibitors, RAL: raltegravir, TDF: tenofovir, /r: boosted with ritonavir.</p><p>Baseline characteristics of the 116 patients.</p
Distribution of NRTI (a) and NNRTI (b) resistance-associated mutations detected in the historical genotypic resistance tests of the patients.
<p>NNRTI: non nucleoside reverse transcriptase inhibitors, NRTI: nucleoside reverse transcriptase inhibitors.</p
Distribution of tenofovir, emtricitabine and rilpivirine plasma concentrations at different time-points.
<p>Distribution of tenofovir, emtricitabine and rilpivirine plasma concentrations at different time-points.</p
Concordance between the 4 methods used to analyze HIV tropism in the 102 patients with UDPS sequences of good quality at D0.
<p>Consensus means that the consensus of UDPS sequences has been used as a surrogate of population sequencing; UDPS means that the full set of pyrosequencing sequences has been used; g2p means that the geno2pheno algorithm has been used for analysis; Pyrotrop means that our in-house software has been used for analysis.</p><p>Concordance between the 4 methods used to analyze HIV tropism in the 102 patients with UDPS sequences of good quality at D0.</p
Baseline characteristics of the 116 patients.
<p>ART: antiretroviral therapy, ATV: atazanavir, DRV: darunavir, EFV: efavirenz, ETR: etravirine, FTC: emtricitabine, IQR: interquartile range, LPV: lopinavir, MVC: maraviroc, NNRTI: non nucleoside reverse transcriptase inhibitors, NRTI: nucleoside reverse transcriptase inhibitors, NVP: nevirapine, PI: protease inhibitors, RAL: raltegravir, TDF: tenofovir, /r: boosted with ritonavir.</p><p>Baseline characteristics of the 116 patients.</p
HIV serological and molecular testing for dually HIV-1 and HIV-2 diagnosis in West Africa.
HIV serological and molecular testing for dually HIV-1 and HIV-2 diagnosis in West Africa.</p
Correlation between FibroScanÂź values and inflammatory biomarkers (Spearman rankâs test).
<p>Correlation between FibroScanÂź values and inflammatory biomarkers (Spearman rankâs test).</p
Characteristics of HIV/HCV co-infected patients (<i>n</i>â=â60).
<p>Continuous variables were expressed as medians and interquartile ranges (IQR), and categorical variables were expressed as numbers and percentages.</p><p>ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma glutamyl transpeptidase.</p
Distribution of plasma HIV-1 viral load at baseline (BL), Week (W)12, W24, W36, W48, W72 and W96.
<p>Distribution of plasma HIV-1 viral load at baseline (BL), Week (W)12, W24, W36, W48, W72 and W96.</p